LEDA Pharma
ActiveSummary
LEDA Pharma has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€51,021) and a net result of €6,990. Equity has been growing by about 23% per year since 2018. Its solvency ranks better than 6% of 12,781 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.1% (low).
Overview
Official details
Source: KBO- Status
- Active since 19-04-2010 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Establishment unit
- 2.188.647.721 3360 Bierbeek, since 19-04-2010
- Financial year end
- 31 December
- Peppol
- Reachable since 27-03-2026
Board and ownership
- Farmacoach AD BVDirector
- FARMACOACH AD100%· score 852025 annual accounts of FARMACOACH AD
- HELMATHEEKconsolidates· score 95annual accounts 2016
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.1%
- Gross margin
- €21,846
- ▲ 3.8%
- Turnover
- ≈ €230,000
- estimated
- Profit
- €6,990
- ▲ 42.4%
- Equity
- -€51,021
- ▲ 12.0%
- Total assets
- €91,792
- ▼ 7.5%
- Negative equity on 31-12-2025
Score breakdownraises riskCapped at 59: negative equityNegative equity -€51,021Liquidity: current ratio 0.14lowers riskSize: total assets €91,792Founded in 2010Show the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 6% of them on solvency, 1% on liquidity, 49% on profitability and 64% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 11 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
- Risk: Negative equitydebts exceed assets in financial year 2025 -€51,021 View
- Caution: Lower solvency than 94% of companies in retail tradesector median 36.6% · 12,781 companies -55.6% View
- Positive: 8 profitable years in a rowprofit 2025: €6,990 8 years View
- Positive: Filed on time since financial year 2021accounts within the deadline every year 5 years View
Recent changes
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as LEDA Pharma: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €73,700 and €129,000, founded between 2007 and 2015.
| Company | Total assets | Gross margin |
|---|---|---|
| LEDA Pharma Bierbeek | €91,792 | €21,846 |
| Rechter Apotheke Sankt Vith | €105,065 | €20,159 |
| PILLPHARM Mouscron | €86,093 | €29,411 |
| INGRID LUYTEN Turnhout | €100,696 | €18,060 |
| ARKOPHAR Zutendaal | €73,718 | €28,413 |
| MARC THONÉ Antwerpen | €93,815 | €33,614 |
| APOTHEEK DE SCHEERDER Gent | €128,527 | €23,955 |
Key facts about LEDA Pharma
- What is the company number of LEDA Pharma?
- The company number of LEDA Pharma is 0825.107.833. The VAT number is the same number with BE in front: BE 0825.107.833.
- Where is LEDA Pharma based?
- The registered office is at Dorpsstraat 29, 3360 Bierbeek.Company details
- What does LEDA Pharma do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of LEDA Pharma?
- The legal form of LEDA Pharma is Private limited company (BV).
- When was LEDA Pharma founded?
- LEDA Pharma was founded on 19-04-2010.
- Is LEDA Pharma still active?
- Yes, LEDA Pharma is an active enterprise in the KBO register.
- What is the turnover of LEDA Pharma?
- The turnover in financial year 2025 is ≈ €230,000. This figure is estimated from the gross margin of €21,846 and 49 comparable companies (NACE 477). It probably lies between €120,000 and €570,000. It is a rough estimate.Financials
- Is LEDA Pharma profitable?
- In financial year 2025, LEDA Pharma made a profit of €6,990.
- Where can I find the annual accounts of LEDA Pharma?
- LEDA Pharma filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of LEDA Pharma due?
- LEDA Pharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.